QiC Hepatitis C is a multi-tiered awards programme supporting  improved patient experience and outcomes through collaborative working with NHS organisations, charities, patient organisation and industry.
Register for newsletters (hepc@qualityincare.org); follow us on Twitter - @QiCProgramme and check our website for upcoming events.
Initiatives are invited from individuals or teams working in the hepatitis C arena in the UK. Whatever the area of patient care, if your initiative or programme relates to hepatitis C in any way, you should enter. Judges are keen to review a wide spectrum of entries and recognise the good practice that we know is out there.

Programmes and initiatives should relate to the period specified in the entry guidelines. Please refer to category description for criteria details.

Please note that judges retain the right to reassign entries to an alternative category than the one into which it has been submitted, if appropriate.

Particular credit will be given to projects which demonstrate results having quality and/or efficiency benefits which could be replicated elsewhere, thereby having a greater impact than their initial focus.

Yes – however we are still interested in hearing about initiatives that benefit patients and may be able to feature them in blogs/newsletters. Please contact Debbie Tuesley at dtuesley@pmlive.com or +44 (0)1372 414243 if you have a great initiative you'd like to share and disseminate.

Download an entry form which has detailed instructions. For further information on how to enter please contact Debbie Tuesley on dtuesley@qualityincare.org or +44 (0)1372 414243.
2017 deadline to be announced.
  1. Download an entry form and save to your computer. 
  2. Complete your entry taking into account category descriptions and judging criteria.
  3. Email your entry and supplementary materials to hepc@qualityincare.org.
When you submit your entry by email, you will receive an email confirming receipt. If you have not received a confirmation email within 2 working days of submitting your entry, please call or email Debbie Tuesley on dtuesley@qualityincare.org or +44 (0)1372 414243.
You can withdraw your entry at any time. However, changes are not permitted to your entry after the submission deadline has passed.
The QiC team is happy to help and guide you through the entry process. Contact Debbie Tuesley on dtuesley@qualityincare.org or +44 (0)1372 414243.
Each entry will be reviewed by a panel of multi-disciplinary hepatitis C experts and scored against the judging criteria.
Finalists will be informed by email and shortlisted entries will be announced on www.qualityincare.org/hepc after the judging day.
Finalists will be invited to the awards ceremony where the winners will be announced.
Finalists and winners in each category will either receive a certificate or a trophy.
Following the awards presentation, the finalists and winners will be announced here on www.qualityincare.org/hepc. The award winning case studies will be featured on the website and shared with hepatitis teams around the UK.  
If your entry is shortlisted, the programme organisers may wish to reproduce a summary of your entry, photographs and any other supporting materials in the winners' booklet or within other materials they produce to promote the programme (eg press materials or on the website). On each entry form there is a section for you to confirm you are happy for your materials to be used in this way. Materials will not be used if you decline permission.

PMGroup will keep all information provided confidential and all judges will sign a confidentiality agreement prior to appointment. Entrants may mark certain sensitive parts of their entry 'not for publication', provided such restrictions are not used unreasonably.

The organisers reserve the right to publish information provided in your summary for subsequent publication. Descriptions of submissions from finalists will be published on QiC Connect, a web-based resource providing practical advice and ideas on how providers can develop or improve service provision and patient outcomes.

QiC Hepatitis C is supported by: